Autopsy of a case of rheumatoid arthritis with severe bicytopoenia due to gelatinous transformation of the bone marrow

References

• Lacaille D, Avina-Zubieta JA, Sayre EC, et al. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis. 2017;76(6):1057–1063.
   Web of Science ®Google Scholar
• van den Hoek J, Boshuizen HC, Roorda LD, et al. Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int. 2017;37(4):487–493.
   PubMed Web of Science ®Google Scholar
• Choi IA, Lee JS, Song YW, et al. Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: a nationwide population-based study. PLoS One. 2019;14(1):e0210471.
   PubMed Web of Science ®Google Scholar
• Loppenthin K, Esbensen BA, Ostergaard M, et al. Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: a nationwide register study. J Comorb. 2019; 9:2235042X19853484.
   Google Scholar
• Poppelaars PB, van Tuyl LHD, Boers M. Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up. Ann Rheum Dis. 2019;78(5):586–589.
   Web of Science ®Google Scholar
• Teke HU, Cansu DU, Korkmaz C. Indications for bone marrow examinations in rheumatology. Rheumatol Int. 2019;39(7):1221–1228.
   Web of Science ®Google Scholar
• Vreugdenhil G, Swaak AJ. Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment. Rheumatol Int. 1990;9(6):243–257.
   Web of Science ®Google Scholar
• Vanni KMM, Lyu H, Solomon DH. Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford)). 2020;59(4):709–717.
   PubMed Web of Science ®Google Scholar
• Bohm J. Gelatinous transformation of the bone marrow: the spectrum of underlying diseases. Am J Surg Pathol. 2000; 24:56–65.
   PubMed Web of Science ®Google Scholar
• Scott JM, Weir DG. Drug-induced megaloblastic change. Clin Haematol. 1980;9(3):587–606.
   Google Scholar
• Sanna A, Firinu D, Zavattari P, et al. Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis. Nutrients. 2018;10(1):68.
   PubMed Web of Science ®Google Scholar
• Zheng J, Kitajima K, Sakai E, et al. Differential effects of GATA-1 on proliferation and differentiation of erythroid lineage cells. Blood. 2006;107(2):520–527.
   Web of Science ®Google Scholar
• Shergill KK, Shergill GS, Pillai HJ. Gelatinous transformation of bone marrow: rare or underdiagnosed? Autops Case Rep. 2017;7(4):8–17.
   Google Scholar
• Schafernak KT. Gelatinous transformation of the bone marrow from anorexia nervosa. Blood. 2016;127(10):1374.
   PubMed Web of Science ®Google Scholar
• Osgood E, Muddassir S, Jaju M, et al. Starvation marrow - gelatinous transformation of bone marrow. J Community Hosp Intern Med Perspect. 2014;4(4). doi:10.3402/jchimp.v4.24811.
   Google Scholar
• Schwarz D, Ponder KL, Feller ER. Delayed diagnoses: nonspecific findings and diagnostic challenges in eating disorders. Case Rep Med. 2009; 2009:841037.
   Google Scholar
• Munfus DL, Menke DM. Case of severe serous fat atrophy. Mayo Clin Proc. 2009;84(7):570.
   Web of Science ®Google Scholar
• Morii K, Yamamoto T, Kishida H, et al. Gelatinous transformation of bone marrow in patients with anorexia nervosa. Intern Med. 2013;52(17):2005–2006.
   Web of Science ®Google Scholar
• Hariz A, Hamdi MS, Boukhris I, et al. Gelatinous Transformation of Bone Marrow in a Patient with Anorexia Nervosa: An Uncommon but Reversible Etiology. Am J Case Rep. 2018; 19:1449–1452.
   Web of Science ®Google Scholar
• Chang J, Park CJ. Gelatinous transformation of the bone marrow in hepatocellular carcinoma. Blood Res. 2015;50(2):71.
   Web of Science ®Google Scholar
• Feng CS. Gelatinous transformation of marrow in a case of acute myelogenous leukemia post-chemotherapy. Am J Hematol. 1991;38(3):220–222.
   PubMed Web of Science ®Google Scholar
• Ram R, Gafter-Gvili A, Okon E, et al. Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect? Acta Haematol. 2008;119(2):104–107.
   Web of Science ®Google Scholar
• Varma N, Bhoria U, Bambery P, et al. Gelatinous transformation of the bone marrow and Leishmania donovani infection. J Trop Med Hyg. 1991;94(5):310–312.
   Web of Science ®Google Scholar
• Stroup JS, Stephens JR, Baker DL. Gelatinous bone marrow in an HIV-positive patient. Proc (Bayl Univ Med Cent)). 2007;20(3):254–256.
   PubMedGoogle Scholar
• Das S, Mishra P, Kar R, et al. Gelatinous marrow transformation: a series of 11 cases from a tertiary care centre in South India. Turk J Haematol. 2014;31(2):175–179.
   Web of Science ®Google Scholar
• Yamamoto M, Belmont HM, Utsunomiya M, et al. Gelatinous transformation of the bone marrow in systemic lupus erythematosus. Lupus. 2009;18(12):1108–1111.
   Web of Science ®Google Scholar
• Obata Y, Tamba S, Yamada Y, et al. Resolution of gelatinous bone marrow transformation following hormone replacement therapy in a patient with primary insufficiency of the adrenal and thyroid glands. Intern Med. 2013;52(17):1931–1936.
   Web of Science ®Google Scholar
• Hermel DJ, Nael A, Lu YT, et al. Gelatinous bone marrow transformation and emergence of clonal Philadelphia-negative cytogenetic abnormalities with excess blasts in a patient with chronic myeloid leukemia treated with dasatinib. Anticancer Drugs. 2019;30(4):416–421.
   Web of Science ®Google Scholar
• Hong FS, Mitchell CA, Zantomio D. Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia. Pathology. 2010;42(1):84–85.
   Web of Science ®Google Scholar